Target intelligence / Profile preview

Plasmodium 80S ribosome (Pf80S)

Target
Pf80S
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The Plasmodium 80S ribosome is the cytosolic protein synthesis machinery of the malaria parasite, essential for its growth and survival across multiple life cycle stages (Sun et al., 2015, Science). It is a large ribonucleoprotein complex consisting of a 40S small subunit and a 60S large subunit that translate messenger RNA into proteins. Although it shares a general architecture with the human 80S ribosome, the Plasmodium version contains unique ribosomal RNA expansion segments and protein isoforms that create parasite-specific structural pockets (Wong et al., 2014, eLife). These differences are exploited in drug discovery to develop selective inhibitors that can distinguish between the parasite and host translation machinery. Compounds such as emetine and mefloquine have been shown to bind to the Plasmodium 80S ribosome, effectively blocking translation elongation or translocation (Wong et al., 2014, eLife). Targeting this ribosome is a validated strategy for developing potent, multi-stage antimalarials, though achieving high selectivity to avoid host toxicity remains a primary challenge. Modern research utilizes high-resolution cryo-electron microscopy to identify these species-specific binding sites for the design of next-generation therapeutics.

Other names
Plasmodium falciparum 80S ribosomeCytosolic ribosome of PlasmodiumMalarial 80S ribosomeMalarial ribosome
02

Mechanism of action

Inhibition of protein synthesis by blocking translation elongation, translocation, or the decoding process on the cytosolic 80S ribosome (Wong et al., 2014, eLife).

03

Biological functions

Protein synthesisTranslationmRNA translation
04

Disease associations

MalariaInfection
05

Safety considerations

Cross-reactivity with human 80S ribosome leading to host toxicity (Wong et al., 2014, eLife)Ototoxicity and cardiotoxicity (associated with non-selective inhibitors like emetine)Development of drug resistance through mutations in ribosomal RNA or proteins
06

Interacting drugs

Emetine

5 more in the full profile.

07

Biomarkers

Parasite clearance ratePlasmodium falciparum histidine-rich protein 2 (PfHRP2)Plasmodium falciparum lactate dehydrogenase (PfLDH)Ribosomal RNA (rRNA) expression levels

Beyond the preview

Go deeper on Plasmodium 80S ribosome (Pf80S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium 80S ribosome (Pf80S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call